NCT06022354View on ClinicalTrials.gov

To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SIM0278 in Chinese Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 23, 2023

Primary Completion Date

March 18, 2025

Study Completion Date

July 22, 2025

Conditions
Healthy Volunteers
Interventions
DRUG

SIM0278 Injection/Placebo

SIM0278 Injection/Placebo

Trial Locations (1)

266001

Affiliated Hospital of Qingdao University, Qingdao

Sponsors
All Listed Sponsors
lead

Jiangsu Simcere Pharmaceutical Co., Ltd.

INDUSTRY

NCT06022354 - To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SIM0278 in Chinese Healthy Subjects | Biotech Hunter | Biotech Hunter